atrasentan has been researched along with Insulin Sensitivity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Correa-Rotter, R; de Zeeuw, D; Gansevoort, RT; Ju, W; Kohan, DE; Lambers Heerspink, HJ; Liew, A; Rossing, P; Smeijer, JD; Tang, SCW | 1 |
| Berthiaume, N; Opgenorth, TJ; Wessale, JL; Zinker, BA | 1 |
| Berthiaume, N; Carlson, CJ; Rondinone, CM; Zinker, BA | 1 |
3 other study(ies) available for atrasentan and Insulin Sensitivity
| Article | Year |
|---|---|
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
Topics: Atrasentan; Diabetes Mellitus, Type 2; Endothelin Receptor Antagonists; Humans; Insulin Resistance; Kidney; Renal Insufficiency, Chronic | 2023 |
Metabolic responses with endothelin antagonism in a model of insulin resistance.
Topics: Animals; Area Under Curve; Atrasentan; Blood Glucose; Endothelin A Receptor Antagonists; Endothelin-1; Fatty Acids, Nonesterified; Insulin; Insulin Resistance; Pyrrolidines; Rats; Rats, Zucker | 2005 |
Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Topics: Animals; Atrasentan; Blood Pressure; Body Weight; Drinking; Endothelin-1; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Liver; Muscle, Skeletal; Obesity; Pyrrolidines; Rats; Rats, Zucker; Signal Transduction | 2005 |